Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
doi: 10.1056/NEJMoa1811744 12 MarsoSPDanielsGHBrown-FrandsenKKristensenPMannJFNauckMAet al
PCOS Spotlight: Tirzepatide's dual GIP/GLP-1 mechanism is uniquely suited for PCOS because the GIP receptor directly improves insulin sensitivity in adipose tissue
The cultural conversation has raced ahead of the clinical evidence
Dosing follows a gradual titration schedule starting low and increasing incrementally to minimise gastrointestinal side effects while the body adjusts
References Wang W
US$ 26.53
US$ 25.43
US$ 28.70
US$ 23.36
US$ 22.84
US$ 22.68
US$ 22.56
